Preprint · OA
via OpenAlex
Repairing Mitochondrial Dysfunction in Disease
Vincenzo Sorrentino, Keir J. Menzies, Johan H. Auwerx
The Annual Review of Pharmacology and Toxicology · 2017 · ▲ 350 citations
Abstract
Mitochondria are essential organelles for many aspects of cellular homeostasis, including energy harvesting through oxidative phosphorylation. Alterations of mitochondrial function not only impact on cellular metabolism but also critically influence whole-body metabolism, health, and life span. Diseases defined by mitochondrial dysfunction(definition) have expanded from rare monogenic disorders in a strict sense to now also include many common polygenic diseases, including metabolic, cardiovascular, neurodegenerative, and neuromuscular diseases. This has led to an intensive search for new therapeutic and preventive strategies aimed at invigorating mitochondrial function by exploiting key components of mitochondrial biogenesis, redox metabolism, dynamics, mitophagy, and the mitochondrial unfolded protein response. As such, new findings linking mitochondrial function to the progression or outcome of this ever-increasing list of diseases has stimulated the discovery and development of the first true mitochondrial drugs, which are now entering the clinic and are discussed in this review.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1146/annurev-pharmtox-010716-104908
- Canonical
- link ↗
- Fetched
- 2026-09-26 MST
Cite this
APA
Sorrentino, V., Menzies, K.J., & Auwerx, J.H. (2017). Repairing Mitochondrial Dysfunction in Disease. <em>The Annual Review of Pharmacology and Toxicology</em>. https://doi.org/10.1146/annurev-pharmtox-010716-104908
Vancouver
Sorrentino V, Menzies KJ, Auwerx JH. Repairing Mitochondrial Dysfunction in Disease. The Annual Review of Pharmacology and Toxicology. 2017. doi:10.1146/annurev-pharmtox-010716-104908.
BibTeX
@unpublished{vincenzo2017Repair,
title = {Repairing Mitochondrial Dysfunction in Disease},
author = {Vincenzo Sorrentino and Keir J. Menzies and Johan H. Auwerx},
journal = {The Annual Review of Pharmacology and Toxicology},
year = {2017},
doi = {10.1146/annurev-pharmtox-010716-104908},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cambridge Prisms Plastics 2024
Open access · CC-BY
Mitochondria as a target of micro- and nanoplastic toxicity
Frontiers in cell and developmental biology 2026
Open access · OA
Mitochondria in health and disease: cellular powerhouses, signaling centers, and drivers of dysfunction.
International Journal of Molecular Sciences 2017
Open access · CC-BY
Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
Quality Matters? The Involvement of Mitochondrial Quality Control in Cardiovascular Disease
Journal of Clinical Investigation 2018
Open access · OA
Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy
npj Metabolic Health and Disease 2025
Open access · CC-BY